Characteristics of Patients with Type 2 Diabetes Mellitus (T2DM) Initiating Therapy with Canagliflozin

被引：0
|
作者：
Martin, Silas C.
Henk, Henry J.
Chow, Wing
机构：
来源：
DIABETES | 2014年 / 63卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1181-P
引用
收藏
页码：A307 / A307
页数：1
相关论文
共 50 条
  • [31] Cause of Hospitalizations in Patients with Type 2 Diabetes Mellitus (T2DM) in the CANVAS Program
    Mahaffey, Kenneth W.
    Ianus, Juliana
    Damaraju, C. V.
    Neal, Bruce
    De Zeeuw, Dick
    Fulcher, Greg
    Pfeifer, Michael
    Matthews, David R.
    [J]. DIABETES, 2019, 68
  • [32] Effect of Canagliflozin (CANA) in Patients with Type 2 Diabetes Mellitus (T2DM) Based on Age and Estimated Glomerular Filtration Rate (eGFR)
    Gilbert, Richard E.
    Weir, Matthew R.
    Fioretto, Paola
    Law, Gordon
    Usiskin, Keith
    Meininger, Gary
    [J]. DIABETES, 2014, 63 : A267 - A267
  • [33] MobiDiabet: Mobile Telemonitoring System for Patients with Type 2 Diabetes Mellitus (T2DM)
    Alcala Juarez, Anakaren
    Hernandez Villegas, Manuel Alejandro
    Dominguez, Eduardo Lopez
    Hernandez Velazquez, Yesenia
    Dominguez Isidro, Saul
    Ovando Diego, Liliana
    Hernandez Sanchez, Olivia
    De La Calleja, Jorge
    Pomares Hernandez, Saul Eduardo
    Medina Nieto, Maria Auxilio
    [J]. APPLIED SCIENCES-BASEL, 2020, 10 (22): : 1 - 36
  • [34] Development and Validation of Yoga Program for Patients with Type 2 Diabetes Mellitus (T2DM)
    Thulasi, Arun
    Kumar, Vinod
    Jagannathan, Aarti
    Angadi, Praveen
    Umamaheswar, Kundapur
    Raghuram, Nagarathna
    [J]. JOURNAL OF RELIGION & HEALTH, 2022, 61 (03): : 1951 - 1965
  • [35] Development and Validation of Yoga Program for Patients with Type 2 Diabetes Mellitus (T2DM)
    Arun Thulasi
    Vinod Kumar
    Aarti Jagannathan
    Praveen Angadi
    Kundapur Umamaheswar
    Nagarathna Raghuram
    [J]. Journal of Religion and Health, 2022, 61 : 1951 - 1965
  • [36] Empagliflozin in Patients With Type 2 Diabetes Mellitus (T2DM) and Renal Impairment (RI)
    Barnett, Anthony H.
    Mithal, Ambrish
    Manassie, Jenny
    Jones, Russell
    Rattunde, Henning
    Woerle, Hans J.
    Broedl, Uli C.
    [J]. DIABETES, 2013, 62 : A286 - A286
  • [37] HDL EFFLUX CAPACITY, AND PARTICLE REMODELLING IN PATIENTS WITH TYPE 1 DIABETES MELLITUS (T1DM) AND TYPE 2 DIABETES MELLITUS (T2DM)
    Byrne, R.
    Curley, S.
    Ahmed, K.
    Ahmed, M.
    Gibney, J.
    Mcgillicuddy, F.
    [J]. ATHEROSCLEROSIS, 2020, 315 : E65 - E66
  • [38] THE PREVALENCE OF MICROALBUMINURIA IN CHILDREN WITH TYPE 2 DIABETES MELLITUS (T2DM)
    Yafi, Michael
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD, 2019, 104 : A250 - A250
  • [39] Type 2 diabetes mellitus (T2DM): Clinical and biochemical characteristics of normal weight versus overweight patients
    Farcasiu, E
    Mota, M
    Morosanu, M
    Guja, C
    Ionescu-Tirgoviste, C
    [J]. DIABETES, 2002, 51 : A225 - A225
  • [40] Gut microbiota influence in type 2 diabetes mellitus (T2DM)
    A. L. Cunningham
    J. W. Stephens
    D. A. Harris
    [J]. Gut Pathogens, 13
12345